Article Listing - Boeh Ingelheim launches largest-ever stroke prevention trial with dipyridamole

INDIA; DRUG REVIEW DELAYS POLICY

3 February 1992

A new review of the drug products which are to remain under government price control is reportedly causing delay in...

PROTEUS INTERNATIONAL "PROCEEDING TO PLAN"

3 February 1992

The six months to September 1991 saw continuing developments for UK computer-aided molecular modelling and drug design company Proteus International....

HOECHST ATTACKED OVER MIFEPRISTONE

3 February 1992

Hoechst Celanese Corp, a US subsidiary of Hoechst-AG, one of the companies behind the manufacturers of the controversial abortifacient drug...

VESTAR'S AMBISOME LAUNCHED IN THE UK

3 February 1992

The first liposomal formulation of a drug has now been launched in the UK, in the form of Vestar's Ambisome,...

ENZON AND ALLELIX IN EGF DEAL

3 February 1992

Enzon has signed an agreement with Allelix Biopharmaceuticals for the development of a modified version of epidermal growth factor, using...

GOOD 1991 RESULTS FOR MERCK AND FOREST LABS

3 February 1992

Fourth quarter and 1991 year-end financial results announced in the USA over the past week were led by the generics...

US APPROVAL FOR SB'S TRIOSTAT

3 February 1992

- SmithKline Beecham has received approval from the US Food and Drug Administration to market Triostat (tri-iodothyronine) its orphan drug...

APPOINTMENTS AT BRISTOL-MYERS SQUIBB

3 February 1992

- At Bristol-Myers Squibb Co, Wesley Thompson has been appointed president of the Bristol-Myers Squibb Consumer Products International division....

FOREST LAB'S ROBIN BURROWS RETIRES

3 February 1992

- Robin Burrows has resigned as vice president of corporate development with Forest Labor-atories Inc, and is presently acting as...

NEW DIRECTOR AT INSALUD

3 February 1992

- Antolin Rodriguez Martinez has been appointed as director of Spain's national institute for health, Insalud.

Showing 94851-94860 of 95337 articles